Literature DB >> 15585007

Hemostatic agents.

Jerrold H Levy1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15585007     DOI: 10.1111/j.0041-1132.2004.04173.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  5 in total

Review 1.  Management of coagulopathy in the setting of acute neurosurgical disease and injury.

Authors:  Marlon Mathews; Richard Newman; E Thomas Chappell
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 2.  Perioperative management of the bleeding patient.

Authors:  K Ghadimi; J H Levy; I J Welsby
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166

Review 3.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

Review 4.  A benefit-risk review of systemic haemostatic agents: part 1: in major surgery.

Authors:  Ian S Fraser; Robert J Porte; Peter A Kouides; Andrea S Lukes
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Effect of fibrin vs cellulose based haemostatic agents with traditional haemostatic procedures in thyroid surgery.

Authors:  Karanikolic Aleksandar; Djordjevic Miodagl; Djordjevic Nebojsa; Golubovic Ilija
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.